Physician profile
Stephen Bennett
NPI 1467524702
$515.26
in general payments reported to CMS, 2019-2025
5 companies · $172 in 2025
The $172 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2020: $128 · 2023: $54.98 · 2024: $39.47 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $266.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $172.41 | 2025 | Prostep Mica, Gravity, Ortholoc 3di |
| Smith+Nephew, INC. | $150.51 | 2019-2023 | Regranex, Collagenase Santyl |
| Horizon Therapeutics Plc | $127.87 | 2020 | |
| Neurocrine Biosciences, INC. | $39.47 | 2024 | Ingrezza |
| Lilly USA, LLC | $25.00 | 2023 | Trulicity, Baqsimi, Humalog |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.